Yung-Luen Yu Selected Research

Sulfasalazine (Azulfidine)

1/2019

Anti-Cancer Effects of Sulfasalazine and Vitamin E Succinate in MDA-MB 231 Triple-Negative Breast Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yung-Luen Yu Research Topics

Disease

39	Neoplasms (Cancer) 08/2021 - 05/2009
13	Breast Neoplasms (Breast Cancer) 03/2019 - 12/2006
11	Hepatocellular Carcinoma (Hepatoma) 04/2021 - 02/2010
9	Triple Negative Breast Neoplasms 01/2021 - 01/2013
5	Neoplasm Metastasis (Metastasis) 04/2021 - 04/2013
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 05/2009
4	Lung Neoplasms (Lung Cancer) 01/2017 - 05/2009
4	Glioblastoma (Glioblastoma Multiforme) 06/2015 - 08/2008
3	Brain Neoplasms (Brain Tumor) 06/2015 - 08/2008
3	Stroke (Strokes) 10/2013 - 04/2013
2	Wounds and Injuries (Trauma) 04/2020 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 06/2015
2	Rheumatoid Arthritis 04/2017 - 09/2014
2	Prostatic Neoplasms (Prostate Cancer) 06/2015 - 07/2014
2	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2015 - 07/2014
2	Pneumonia (Pneumonitis) 04/2014 - 09/2013
2	Chronic Hepatitis B 01/2014 - 01/2012
1	Nasopharyngeal Carcinoma 04/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Cough 01/2018
1	Chondrosarcoma 01/2018
1	Glioma (Gliomas) 01/2018
1	Pain (Aches) 01/2018
1	Skin Neoplasms (Skin Cancer) 01/2017
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2017
1	Mouth Neoplasms (Oral Cancer) 05/2016
1	Leukemia 06/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2015

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 08/2021 - 05/2012
5	ErbB Receptors (EGF Receptor)IBA 07/2014 - 07/2009
4	Pharmaceutical PreparationsIBA 01/2021 - 09/2014
4	MicroRNAs (MicroRNA)IBA 07/2020 - 12/2013
4	Estrogen ReceptorsIBA 01/2020 - 03/2011
4	human ERBB2 proteinIBA 01/2020 - 04/2013
4	Ribonucleases (Ribonuclease)IBA 06/2015 - 03/2011
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 11/2013
3	Methotrexate (Mexate)FDA LinkGeneric 03/2019 - 09/2014
3	Histones (Histone)IBA 01/2018 - 07/2014
3	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 09/2013
3	Peptides (Polypeptides)IBA 01/2017 - 01/2013
3	Messenger RNA (mRNA)IBA 01/2014 - 04/2011
3	Interleukin-15 (Interleukin 15)IBA 05/2012 - 05/2009
2	praeruptorin AIBA 04/2021 - 04/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2016
2	Enhancer of Zeste Homolog 2 ProteinIBA 07/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2012
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2017 - 09/2014
2	TubulinIBA 01/2016 - 06/2015
2	DNA-Activated Protein KinaseIBA 06/2015 - 09/2012
2	Phosphotransferases (Kinase)IBA 06/2015 - 04/2013
2	Caspase 9IBA 06/2015 - 09/2014
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2014 - 01/2013
2	Polysaccharides (Glycans)IBA 01/2014 - 01/2012
2	Tyrosine Kinase InhibitorsIBA 11/2013 - 04/2011
2	Lapatinib (GW572016)FDA Link 11/2013 - 04/2013
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2013 - 12/2006
2	Epidermal Growth Factor (EGF)IBA 09/2010 - 07/2009
2	butylidenephthalideIBA 02/2010 - 08/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2021
1	capsanthinIBA 01/2021
1	Chemokine ReceptorsIBA 07/2020
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2020
1	salvianolic acid AIBA 04/2020
1	anomalinIBA 04/2020
1	praeruptorin CIBA 04/2020
1	Hormones (Hormone)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	mangostinIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	LycopeneIBA 01/2020
1	Succinic Acid (Succinate)IBA 03/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2019
1	Vitamin E FDA LinkGeneric 03/2019
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2019
1	Sulfates (Sulfates, Inorganic)IBA 01/2019
1	alpha-Tocopherol FDA Link 01/2019
1	Cyclin B1IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	aristolochic acid I (aristolochic acid)IBA 01/2018
1	Polycomb Repressive Complex 2IBA 01/2018
1	Complementary DNA (cDNA)IBA 01/2018
1	BAY 11-7085IBA 01/2018
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 04/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Vascular Endothelial Growth Factor CIBA 01/2017
1	InflammasomesIBA 01/2017
1	Nicotine FDA Link 01/2017
1	Environmental CarcinogensIBA 05/2016
1	gallocatechol (epigallocatechin)IBA 03/2016
1	sulforaphaneIBA 03/2016
1	Checkpoint Kinase 1IBA 06/2015
1	Checkpoint Kinase 2IBA 06/2015

Therapy/Procedure

10	Therapeutics 01/2021 - 05/2009
5	Immunotherapy 08/2021 - 05/2009
5	Drug Therapy (Chemotherapy) 01/2020 - 08/2008
3	Radiotherapy 07/2014 - 09/2012